AI-generated summary
This randomised placebo-controlled trial in Brazil compared photobiomodulation therapy with placebo in 148 patients with chronic nonspecific low back pain, all of whom also received an educational booklet. The authors report no clinically important difference between groups in pain intensity or disability at 4 weeks, and no adverse events were reported. The study was blinded, but the abstract does not describe its wavelength or dose.
- Participants
- 148
- Who or what was studied
- Patients with chronic nonspecific low back pain treated at an outpatient physical therapy clinic in Brazil
- Limits stated in the abstract
- The abstract does not state the wavelength or dosing parameters of the photobiomodulation therapy used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Placebo-controlled, Confidence interval, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.